Therapeutic efficacy of Pioglitazone for Non-Alcoholic Fatty Liver Desease(NAFLD) patients with impaired glucose tolerance or type 2 diabetes
Not Applicable
- Conditions
- on-Alcoholic Fatty Liver Disease
- Registration Number
- JPRN-UMIN000001035
- Lead Sponsor
- Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not consent to enroll to the study Patients with contraindication for pioglitazone Patients with malignant disease Others who are not suitable to enroll to the study from the physicians points of view
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method